scout
|Videos|April 15, 2022

Single-Agent versus Combination Therapy in Metastatic Prostate Cancer

Scott Tagawa, MD, MS, FACP, compares the use of single-agent regimens versus combination regimens in the treatment of metastatic prostate cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME